Galmed Pharmaceuticals Ltd. (GLMD)
Market Open
12 Jun, 15:10
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
0. 61
-0.01
-0.9579%
$
4M Market Cap
- P/E Ratio
- Div Yield
98,178 Volume
-1.29 Eps
$ 0.62
Previous Close 
Want to track GLMD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
GLMD Earnings Reports FAQ
What is the earnings per share (EPS) for GLMD?
The current EPS is -1.29.
What is the company's earnings growth rate?
Galmed Pharmaceuticals Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Galmed Pharmaceuticals Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Galmed Pharmaceuticals Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for GLMD at this time, as Galmed Pharmaceuticals Ltd has no recent EPS data to calculate it.
